Citicoline in vascular cognitive impairment and vascular dementia after stroke

Stroke

Volumn 42, Issue SUPPL. 1, 2011, Pages

  Álvarez Sabín, Jose ^a   Román, Gustavo C ^b  

^a UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^b HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

Citicoline; Cognition; Dementia; Neuroprotection; Stroke complications; Stroke recovery; Vascular cognitive impairment; Vascular dementia

Indexed keywords

CITICOLINE; NEUROPROTECTIVE AGENT; NOOTROPIC AGENT;

ALZHEIMER DISEASE; ATTENTION; BRAIN DAMAGE; CEREBROVASCULAR DISEASE; CLINICAL TRIAL; COGNITIVE DEFECT; CONFERENCE PAPER; DRUG SAFETY; EXECUTIVE FUNCTION; HUMAN; MULTIINFARCT DEMENTIA; NERVE REGENERATION; PRIORITY JOURNAL; STROKE; TREATMENT INDICATION; BRAIN ISCHEMIA; CLINICAL TRIAL (TOPIC); COGNITION; CONVALESCENCE; DRUG EFFECT; PATHOPHYSIOLOGY; REVIEW;

ALZHEIMER DISEASE; BRAIN ISCHEMIA; CLINICAL TRIALS AS TOPIC; COGNITION; CYTIDINE DIPHOSPHATE CHOLINE; DEMENTIA, VASCULAR; HUMANS; NEUROPROTECTIVE AGENTS; NOOTROPIC AGENTS; RECOVERY OF FUNCTION; STROKE;

EID: 84856806411     PISSN: 00392499     EISSN: 15244628     Source Type: Journal    
DOI: 10.1161/STROKEAHA.110.606509     Document Type: Conference Paper

References (43)

1. Ivan CS, Seshadri S, Beiser A, Au R, Kase CS, Kelly-Hayes M, Wolf PA. Dementia after stroke: the Framingham Study. Stroke. 2004;35: 1264-1268. (Pubitemid 38697439)
2. Leys D, Hénon H, Mackowiak-Cordoliani MA, Pasquier F. Poststroke dementia. Lancet Neurol. 2005;4:752-759. (Pubitemid 41457291)
3. O'Brien JT, Erkinjuntti T, Reisberg B, Roman G, Sawada T, Pantoni L, Bowler JV, Ballard C, DeCarli C, Gorelick PB, Rockwood K, Burns A, Gauthier S, DeKosky ST. Vascular cognitive impairment. Lancet Neurol. 2003;2:89-98. (Pubitemid 37443329)
4. Sachdev P. Vascular cognitive disorder. Int J Geriatr Psychiatry. 1999; 14:402-403.
5. Román GC, Sachdev P, Royall DR, Bullock RA, Orgogozo JM, López-Pousa S, Arizaga R, Wallin A. Vascular cognitive disorder: a new diagnostic category updating vascular cognitive impairment and vascular dementia. J Neurol Sci. 2004;226:81-87. (Pubitemid 39505412)
6. Román GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, García JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, Moody DM, O'Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett A, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993;43:250-260. (Pubitemid 23060253)
7. Rockwood K. Subtypes of vascular dementia. Alzheimer Dis Assoc Disord. 1999;13(Suppl 3):S59-S65.
8. Rasquin SM, Verhey FR, Lousberg R, Winkens I, Lodder J. Vascular cognitive disorders: memory, mental speed and cognitive flexibility after stroke. J Neurol Sci 2002;203-204:115-119. (Pubitemid 35291187)
9. Madureira S, Guerreiro M, Ferro JM. Dementia and cognitive impairment three months after stroke. Eur J Neurol. 2001;8:621-627. (Pubitemid 35015229)
10. Rasquin SM, Verhey FR, van Oostenbrugge RJ, Lousberg R, Lodder J. Demographic and CT scan features related to cognitive impairment in the first year after stroke. J Neurol Neurosurg Psychiatry. 2004;75: 1562-1567. (Pubitemid 39430608)
11. Wentzel C, Rockwood K, MacKnight C, Hachinski V, Hogan DB, Feldman H, Østbye T, Wolfson C, Gauthier S, Verreault R, McDowell I. Progression of impairment in patients with vascular cognitive impairment without dementia. Neurology. 2001;57:714-716. (Pubitemid 32783007)
12. Savva GM, Stephan BC, Alzheimer's Society Vascular Dementia Systematic Review Group. Epidemiological studies of the effect of stroke on incident dementia: a systematic review. Stroke 2010;41:e41-e46.
13. Román GC. Vascular dementia may be the most common form of dementia in the elderly. J Neurol Sci 2002;203-204:7-10. (Pubitemid 35287368)
14. Fotuhi M, Hachinski V, Whitehouse PJ. Changing perspectives regarding late-life dementia. Nat Rev Neurol. 2009;5:649-658.
15. Dolan H, Crain B, Troncoso J, Resnick SM, Zonderman AB, Obrien RJ. Atherosclerosis, dementia, and Alzheimer disease in the Baltimore Longitudinal Study of Aging cohort. Ann Neurol. 2010;68:231-240.
16. Zekry D, Hauw JJ, Gold G. Mixed dementia: epidemiology, diagnosis, and treatment. J Am Geriatr Soc. 2002;50:1431-1438.
17. Reitz C, Bos MJ, Hofman A, Koudstaal PJ, Breteler MM. Prestroke cognitive performance, incident stroke, and risk of dementia: the Rotterdam Study. Stroke. 2008;39:36-41.
18. Clark WM, Warach SJ, Pettigrew LC, Gammans RE, Sabounjian LA. A randomized dose-response trial of citicoline in acute ischemic stroke patients. Citicoline Stroke Study Group. Neurology. 1997;49:671-678. (Pubitemid 27428003)
19. Clark WM, Williams BJ, Selzer KA, Zweifler RM, Sabounjian LA, Gammans RE. A randomized efficacy trial of citicoline in patients with acute ischemic stroke. Stroke. 1999;30:2592-2597.
20. Clark WM, Wechsler LR, Sabounjian LA, Schwiderski UE, Citicoline Stroke Study Group. A phase III randomized efficacy trial of 2000 mg citicoline in acute ischemic stroke patients. Neurology 2001;57: 1595-1602. (Pubitemid 33055476)
21. Warach S, Pettigrew LC, Dashe JF, Pullicino P, Lefkowitz DM, Sabounjian L, Harnett K, Schwiderski U, Gammans R. Effect of citicoline on ischemic lesions as measured by diffusion-weighted magnetic resonance imaging. Citicoline 010 Investigators. Ann Neurol. 2000;48:713-722.
22. Secades JJ, Lorenzo JL. Citicoline: pharmacological and clinical review, 2006 update. Methods Find Exp Clin Pharmacol. 2006;28(Suppl B):1-56. (Pubitemid 44569736)
23. Ulus IH, Wurtman RJ, Mauron C, Blusztajn JK. Choline increases acetylcholine release and protects against the stimulation-induced decrease in phosphatide levels within membranes of rat corpus striatum. Brain Res. 1989;484:217-227. (Pubitemid 19100082)
24. Conant R, Schauss AG. Therapeutic applications of citicoline for stroke and cognitive dysfunction in the elderly: a review of the literature. Altern Med Rev. 2004;9:17-31. (Pubitemid 38364879)
25. Parnetti L, Mignini F, Tomassoni D, Traini E, Amenta F. Cholinergic precursors in the treatment of cognitive impairment of vascular origin: ineffective approaches or need for re-evaluation? J Neurol Sci. 2007;257: 264-269. (Pubitemid 46856504)
26. Alvarez XA, Sampedro C, Lozano R, Cacabelos R. Citicoline protects hippocampal neurons against apoptosis induced by brain beta-amyloid deposits plus cerebral hypoperfusion in rats. Methods Find Exp Clin Pharmacol. 1999;21:535-540. (Pubitemid 29535809)
27. Lee HJ, Kang JS, Kim YI. Citicoline protects against cognitive impairment in a rat model of chronic cerebral hypoperfusion. J Clin Neurol. 2009;5:33-38.
28. Hurtado O, Cárdenas A, Pradillo JM, Morales JR, Ortego F, Sobrino T, Castillo J, Moro MA, Lizasoain I. A chronic treatment with CDP-choline improves functional recovery and increases neuronal plasticity after experimental stroke. Neurobiol Dis. 2007;26:105-111. (Pubitemid 46436490)
29. Silveri MM, Dikan J, Ross AJ, Jensen JE, Kamiya T, Kawada Y, Renshaw PF, Yurgelun-Todd DA. Citicoline enhances frontal lobe bioenergetics as measured by phosphorus magnetic resonance spectroscopy. NMR Biomed. 2008;21:1066-1075.
30. Dávalos A, Castillo J, Alvarez-Sabín J, Secades JJ, Mercadal J, López S, Cobo E, Warach S, Sherman D, Clark WM, Lozano R. Oral citicoline in acute ischemic stroke: an individual patient data pooling analysis of clinical trials. Stroke. 2002;33:2850-2857. (Pubitemid 35462855)
31. Saver JL. Citicoline: update on a promising and widely available agent for neuroprotection and neurorepair. Rev Neurol Dis. 2008;5:167-177.
32. Cobo E, Secades JJ, Miras F, González JA, Saver JL, Corchero C, Rius R, Dàvalos A. Boosting the chances to improve stroke treatment. Stroke. 2010;41:e143-e50.
33. Cacabelos R, Alvarez XA, Franco-Maside A, Fernández-Novoa L, Caamaño J. Effect of CDP-choline on cognition and immune function in Alzheimer's disease and multi-infarct dementia. Ann NY Acad Sci. 1993; 695:321-323. (Pubitemid 23348285)
34. Cohen RA, Browndyke JN, Moser DJ, Paul RH, Gordon N, Sweet L. Long-term citicoline (cytidine diphosphate choline) use in patients with vascular dementia: neuroimaging and neuropsychological outcomes. Cerebrovasc Dis. 2003;16:199-204. (Pubitemid 36928609)
35. Fioravanti M, Yanagi M. Cytidinediphosphocholine (CDP-choline) for cognitive and behavioural disturbances associated with chronic cerebral disorders in the elderly. Cochrane Database Syst Rev 2005;18: CD000269.
36. Fioravanti M, Buckley AE. Citicoline (Cognizin) in the treatment of cognitive impairment. Clin Interv Aging. 2006;1:247-251.
37. Ye J, Lin H, Mu J, Cui X, Ying H, Lin M, Wu L, Weng J, Lin X. Effect of basic fibroblast growth factor on hippocampal cholinergic neurons in a rodent model of ischaemic encephalopathy. Basic Clin Pharmacol Toxicol 2010 Jul 1 [epub ahead of print].
38. Sobrino T, Hurtado O, Moro MA, Rodríguez-Yáñez M, Castellanos M, Brea D, Moldes O, Blanco M, Arenillas JF, Leira R, Dávalos A, Lizasoain I, Castillo J. The increase of circulating endothelial progenitor cells after acute ischemic stroke is associated with good outcome. Stroke. 2007;38:2759-2764. (Pubitemid 47494015)
39. Álvarez-Sabín J, Ortega G, Jacas C, Quintana M, Ribó M, Santamarina E, Maisterra O, Molina C, Montaner J, Román G. Citicoline treatment prevents neurocognitive decline after a first ischemic stroke (Poster 743). Cerebrovasc Dis 2010;29(Suppl 2):268.
40. Ovbiagele B, Kidwell CS, Starkman S, Saver JL. Potential role of neuroprotective agents in the treatment of patients with acute ischemic stroke. Curr Treat Options Neurol. 2003;5:367-375.
41. Labiche LA, Grotta JC. Clinical trials for cytoprotection in stroke. NeuroRx. 2004;1:46-70. (Pubitemid 46591882)
42. Segura T, Calleja S, Jordan J. Recommendations and treatment strategies for the management of acute ischemic stroke. Expert Opin Pharmacother. 2008;9:1071-1085. (Pubitemid 351727806)
43. García-Cobos R, Frank-García A, Gutiérrez- Fernández M, Díez-Tejedor E. Citicoline, use in cognitive decline: vascular and degenerative. J Neurol Sci. 2010;299:188-192.